Ada Patient Finder -- Daily Briefing
Saturday, February 07, 2026 -- 8:31 AM ET
Snapshot: 2026-02-06
Pipeline Snapshot
€97,588,666
Total Pipeline (Unweighted)
€7,951,386
Weighted Pipeline
135
Open Opps
€0
Closing This Quarter
2
Calls Yesterday
2.1
7-Day Avg Calls
27
Stale Deals
Stage Moves (Last 24h)
No stage changes in the last 24 hours
Pipeline Changes
No pipeline changes
Stale Deals (14+ Days Since Last Contact)
Crohns Colitis Foundation
372d No Contact
Jacob Plummer | Qualification | 5% |
€424,569
Ontario Enhancements - Suicide Pop Up - Delivery
262d No Contact
Simon Wolpert | Qualification | 5% |
€247,705
Ontario SOW9 - Health Care Connect (Primary Care Attachment) - Planning Only
202d No Contact
Simon Wolpert | Proposal | 30% |
€30,963
Astrazeneca - Wainua
155d No Contact
Usaid Cheema | Qualification | 5% |
€500,000
Walgreens/Boots
151d No Contact
Randal Whitmore | Qualification | 5% |
€424,569
Patient Finder for Temple Health
150d No Contact
Randal Whitmore | Qualification | 5% |
€424,569
Health 811 SOW9 - HCC + Survey Planning + Delivery
143d No Contact
Simon Wolpert | Proposal | 30% |
€92,889
DKV Seguros
137d No Contact
Johannes Vonhuelsen | Discovery | 10% |
€486,000
GSK - Shingrix
121d No Contact
Usaid Cheema | Qualification | 5% |
€424,569
Alberta Health Services - Patient Portal (via Orion & Telus/IBM)
90d No Contact
Simon Wolpert | Qualification | 5% |
€4,799,302
+17 more stale deals
No Decision Maker Engaged
AbbVie - Botox
No DM
Usaid Cheema | Qualification | 5% |
€424,569
AbbVie - Rinvoq
No DM
Usaid Cheema | Qualification | 5% |
€424,569
AbbVie - Vraylar
No DM
Usaid Cheema | Qualification | 5% |
€500,000
ACADIA Pharmaceuticals | Daybue | Rett syndrome
No DM
Usaid Cheema | Qualification | 5% |
€424,569
Acorda Therapeutics | Ampyra | Multiple sclerosis (improve walking)
No DM
Usaid Cheema | Qualification | 5% |
€424,569
Aetna a CVS Health Company
No DM
Simon Wolpert | Qualification | 5% |
€254,741
Alberta Health Services - Patient Portal (via Orion & Telus/IBM)
No DM
Simon Wolpert | Qualification | 5% |
€4,799,302
Alkermes - Libalvi
No DM
Usaid Cheema | Qualification | 5% |
€500,000
+20 more
Flagged Calls (< 3.0)
No flagged calls
Calls Yesterday (2)
API - status update
27m
Participants:
Social Check-in
48m
Participants:
Top Deals by Value
GNAL
Qualification | 5%
€20,500,000
Biogen | Friedreichs Ataxia | Global - Phase 2
Qualification | 5%
€6,000,000
Blue Shield of California
Proposal | 30%
€5,519,403
Alberta Health Services - Patient Portal (via Orion & Telus/IBM)
Qualification | 5%
€4,799,302
Resmed Phase 2
Qualification | 5%
€2,547,417
SANOFI | Diabetes | TZIELD | US - Phase 2
Discovery | 10%
€2,547,417
Biogen Germany FA extension
Discovery | 10%
€2,100,000
Blue Cross Blue Shield Arizona
Qualification | 5%
€1,443,536
Meetings Today
No meetings scheduled
System Health
Cron Jobs
0 active
Background Tasks
✓ healthy